Clinical Trial Update: Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine [EARLY_Phase 1]

View source ↗

Summary

Emory University is conducting an early-phase 1 trial to explore whether glutamatergic adaptation to stress underpins anhedonia and treatment response to ketami…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Emory University | Conditions: Major Depressive Disorder | EARLY_Phase 1 | Status: RECRUITING